These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8950950)

  • 21. Attenuating effect of a thromboxane synthetase inhibitor (OKY-046) on bronchial responsiveness to methacholine is specific to bronchial asthma.
    Fujimura M; Sakamoto S; Matsuda T
    Chest; 1990 Sep; 98(3):656-60. PubMed ID: 2203618
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of thromboxane A2 synthetase inhibitor on immediate-type hypersensitivity reactions.
    Nakagawa T; Miyamoto T; Urata C; Mano K; Yukawa T; Makino S
    Int Arch Allergy Appl Immunol; 1987; 82(3-4):539-40. PubMed ID: 2437053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological modulation of antigen-induced airway hyperresponsiveness by thromboxane A2 inhibitors in guinea pigs.
    Nagai H; Tsuji F; Goto S; Koda A
    Biol Pharm Bull; 1993 Nov; 16(11):1099-103. PubMed ID: 8312863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thromboxane A2 production in allergen-induced immediate and late asthmatic responses. Its possible role in inducing the late response.
    Iwamoto I; Ra C; Sato T; Tomioka H; Yoshida S
    J Asthma; 1988; 25(3):117-24. PubMed ID: 3182583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of ozagrel (OKY-046), a thromboxane synthetase inhibitor, on theophylline pharmacokinetics in asthmatic patients.
    Kawakatsu K; Kino T; Yasuba H; Kawaguchi H; Tsubata R; Satake N; Oshima S
    Int J Clin Pharmacol Ther Toxicol; 1990 Apr; 28(4):158-63. PubMed ID: 2338368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thromboxane A2 inhibition: therapeutic potential in bronchial asthma.
    Dogné JM; de Leval X; Benoit P; Delarge J; Masereel B
    Am J Respir Med; 2002; 1(1):11-7. PubMed ID: 14720071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An airway hyperresponsiveness model in rat allergic asthma.
    Misawa M; Sugiyama Y
    Arerugi; 1993 Feb; 42(2):107-14. PubMed ID: 8507151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Inhibitory effects of OKY-046.HCl, a selective thromboxane (TX) A2 synthetase inhibitor, on platelet activating factor (PAF)-induced airway hyperresponsiveness in guinea pigs].
    Takehana Y; Hamano S; Kikuchi S; Kusama H; Komatsu H; Okegawa T; Ikeda S
    Nihon Yakurigaku Zasshi; 1990 Jan; 95(1):21-30. PubMed ID: 2303203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Bronchial hyperresponsiveness to histamine induced by intravenous administration of thromboxane A2 (TXA2) in guinea-pigs].
    Tsukagoshi H; Kurosawa M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Dec; 29(12):1532-7. PubMed ID: 1808375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of transient airway hyperresponsiveness by exposure to 4 ppm nitrogen dioxide in guinea pigs.
    Kobayashi T; Shinozaki Y
    J Toxicol Environ Health; 1992 Nov; 37(3):451-61. PubMed ID: 1433380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of inhibition of thromboxane A2 synthesis in aspirin-induced asthma.
    Szczeklik A; Dworski R; Nizankowska E; Gajewski P
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():1073-9. PubMed ID: 2960148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Revisiting the usefulness of thromboxane-A2 modulation in the treatment of bronchoconstriction in asthma.
    Hernandez JM; Janssen LJ
    Can J Physiol Pharmacol; 2015 Feb; 93(2):111-7. PubMed ID: 25581104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibitory effect of a selective thromboxane synthetase inhibitor, OKY-046, on acetaldehyde-induced bronchoconstriction in asthmatic patients.
    Myou S; Fujimura M; Nishi K; Ohka T; Masuda T
    Chest; 1994 Nov; 106(5):1414-8. PubMed ID: 7956393
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A double-blind, placebo-controlled trial of the thromboxane synthetase blocker OKY-046 on bronchial hypersensitivity in bronchial asthma patients.
    Kunitoh H; Watanabe K; Nagatomo A; Okamoto H; Nakagawa T
    J Asthma; 1998; 35(4):355-60. PubMed ID: 9669829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Thromboxane A2 receptor antagonist in asthma therapy].
    Endo S; Akiyama K
    Nihon Rinsho; 1996 Nov; 54(11):3045-8. PubMed ID: 8950952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of the infusion of OKY-046, a thromboxane A2 synthase inhibitor, on urinary metabolites of prostacyclin and thromboxane A2 in healthy human subjects.
    Morio H; Hirai A; Terano T; Tamura Y; Yoshida S
    Thromb Haemost; 1993 Mar; 69(3):276-81. PubMed ID: 8470052
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Molecular pharmacology and application to the bronchial asthma of thromboxane A2 antagonists].
    Kohno S
    Nihon Rinsho; 1996 Feb; 54(2):551-8. PubMed ID: 8838113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of ozagrel hydrochloride, a thromboxane synthetase inhibitor, on alcoholic beverage-induced bronchoconstriction in asthmatic patients.
    Myou S; Fujimura M; Nishi K; Kita T; Kurashima K; Tachibana H; Ishiura Y; Nakao S
    Prostaglandins Leukot Essent Fatty Acids; 2002 Apr; 66(4):397-401. PubMed ID: 12054909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of CS-518, a thromboxane synthase inhibitor, on the asthmatic response.
    Yamaguchi T; Mukaiyama O; Itoh K; Satoh Y; Terada A; Iizuka Y
    Eur J Pharmacol; 1993 May; 236(1):43-50. PubMed ID: 8319745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Research and development of ozagrel, a highly selective inhibitor of TXA2 synthase].
    Nakazawa M; Iizuka K; Ujiie A; Hiraku S; Ohki S
    Yakugaku Zasshi; 1994 Dec; 114(12):911-33. PubMed ID: 7869235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.